Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Castellano

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
Clinical Chemistry|October 20, 2017
Adipose Tissue LPL Methylation is Associated with Triglyceride Concentrations in the Metabolic SyndromeDaniel Castellano-Castillo, Isabel Moreno-Indias, José Carlos Fernández-García, et al.
The Oncologist|May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR StudyJaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
Oncology Research and Treatment|March 18, 2021
Seizures and Neuropsychiatric Toxicity in Patients with Non-Metastatic CRPC Treated with New Antiandrogens: Systematic Review and Meta-AnalysisRaquel Sopeña Sutil, Jorge Silva Ruiz, Borja Garcia Gomez, et al.
Journal of Clinical Medicine|January 16, 2019
Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Inflammatory Candidate Genes and Metabolic VariablesDaniel Castellano-Castillo, Isabel Moreno-Indias, Lidia Sanchez-Alcoholado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinomaEric Angevin, Jose A Lopez-Martin, Chia-Chi Lin, et al.
Cancer Treatment Reviews|November 26, 2011
Recommendations for the optimal management of early and advanced urothelial carcinomaDaniel Castellano, Joan Carles, Emilio Esteban, et al.
Oncology|October 2, 2013
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB)Cora N Sternberg, Iwona A Skoneczna, Daniel Castellano, et al.
Diabetes Care|September 19, 2018
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control StudyIsabel Leiva-Gea, Lidia Sánchez-Alcoholado, Beatriz Martín-Tejedor, et al.
Lung Cancer (Amsterdam, Netherlands)|April 11, 2007
Prognostic value of KIT expression in small cell lung cancerAna López-Martin, Claudio Ballestín, Rocío Garcia-Carbonero, et al.
European Urology|May 2, 2015
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinomaMeta H M Diekstra, Jesse J Swen, Epie Boven, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
Clinical Chemistry|October 20, 2017
Adipose Tissue LPL Methylation is Associated with Triglyceride Concentrations in the Metabolic SyndromeDaniel Castellano-Castillo, Isabel Moreno-Indias, José Carlos Fernández-García, et al.
The Oncologist|May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR StudyJaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
Oncology Research and Treatment|March 18, 2021
Seizures and Neuropsychiatric Toxicity in Patients with Non-Metastatic CRPC Treated with New Antiandrogens: Systematic Review and Meta-AnalysisRaquel Sopeña Sutil, Jorge Silva Ruiz, Borja Garcia Gomez, et al.
Journal of Clinical Medicine|January 16, 2019
Altered Adipose Tissue DNA Methylation Status in Metabolic Syndrome: Relationships Between Global DNA Methylation and Specific Methylation at Adipogenic, Lipid Metabolism and Inflammatory Candidate Genes and Metabolic VariablesDaniel Castellano-Castillo, Isabel Moreno-Indias, Lidia Sanchez-Alcoholado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinomaEric Angevin, Jose A Lopez-Martin, Chia-Chi Lin, et al.
Cancer Treatment Reviews|November 26, 2011
Recommendations for the optimal management of early and advanced urothelial carcinomaDaniel Castellano, Joan Carles, Emilio Esteban, et al.
Oncology|October 2, 2013
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB)Cora N Sternberg, Iwona A Skoneczna, Daniel Castellano, et al.
Diabetes Care|September 19, 2018
Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control StudyIsabel Leiva-Gea, Lidia Sánchez-Alcoholado, Beatriz Martín-Tejedor, et al.
Lung Cancer (Amsterdam, Netherlands)|April 11, 2007
Prognostic value of KIT expression in small cell lung cancerAna López-Martin, Claudio Ballestín, Rocío Garcia-Carbonero, et al.
European Urology|May 2, 2015
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinomaMeta H M Diekstra, Jesse J Swen, Epie Boven, et al.
Pageof 27